Clinical trial
Prospective Observational Study to Evaluate the Safety of Treatment With A"LLERGOVAC® HIMENÓPTEROS" in Patients Sensitized to This Venom
NCT04112797 is registered in ClinicalTrials.gov with Roxall Medicina España S.A as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Observational Study to Evaluate the Safety of Treatment With A"LLERGOVAC® HIMENÓPTEROS" in Patients Sensitized to This Venom
- Lead sponsor
- Roxall Medicina España S.A
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 23, 2019
- Completion date
- November 30, 2023
- Enrollment
- 50 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
allergy to himenoptera venom